Alteplase vs. Tenecteplase: An In-depth Analysis of Their Relative Effectiveness in Treating Acute Ischemic Stroke
Dear Editor, Stroke stands as the second-leading cause of death worldwide [1, 2]. Each year, over 12 million individuals are impacted by stroke, resulting in approximately 6.5 million fatalities [1]. Stroke globally ranks as the third-leading factor causing a combination of death and disability [...
Saved in:
| Main Authors: | Muhammad Junaid Azhar, Ayesha Imran Butt |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pakistan Medical Association
2024-10-01
|
| Series: | Journal of the Pakistan Medical Association |
| Subjects: | |
| Online Access: | https://jpma.org.pk/index.php/public_html/article/view/20630 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tenecteplase versus alteplase in patients with acute ischemic stroke: an updated systematic review and meta-analysis
by: Abdelmonam M. Hagag, et al.
Published: (2025-08-01) -
Tenecteplase compared to alteplase in real-world outcome: A Swedish Stroke Register study
by: Mikael Skärlund, et al.
Published: (2024-10-01) -
Tenecteplase vs alteplase as bridging thrombectomy in ischemic stroke patients: a systematic review and meta analysis
by: Salim Harris, et al.
Published: (2025-08-01) -
Tenecteplase Versus Alteplase in Acute Ischemic Stroke in Chinese Patients: Protocol for the ORIGINAL Study
by: Xia Meng, et al.
Published: (2024-07-01) -
Efficacy and Safety of Various Intravenous Thrombolytics for Acute Ischemic Stroke (AIS) at Various Dosages: A Systematic Review and Network Meta-Analysis
by: Yibin Hu, et al.
Published: (2024-12-01)